The Rotterdam Study. Design update and major findings between 2020 and 2024-Reference-Cited by-同舟云学术

The Rotterdam Study. Design update and major findings between 2020 and 2024

Published:2024-02 Issue:2 Volume:39 Page:183-206
ISSN:0393-2990
Container-title:European Journal of Epidemiology
language:en
Short-container-title:Eur J Epidemiol

Author:

Ikram M. Arfan^ORCID,Kieboom Brenda C.T.,Brouwer Willem Pieter,Brusselle Guy,Chaker Layal,Ghanbari Mohsen,Goedegebure André,Ikram M. Kamran,Kavousi Maryam,de Knegt Rob J.,Luik Annemarie I.,van Meurs Joyce,Pardo Luba M.,Rivadeneira Fernando,van Rooij Frank J.A.,Vernooij Meike W.,Voortman Trudy,Terzikhan Natalie

Funder

ZonMw

Nederlandse Federatie van Universitair Medische Centra

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10654-023-01094-1.pdf

Reference199 articles.

1. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991;7(4):403-22.

2. Aribas E, Roeters van Lennep JE, De Rijke YB, et al. Sex steroids and sex steroid-binding globulin levels amongst middle-aged and elderly men and women from general population. Eur J Clin Invest. 2022;52(12):e13866.

3. Aribas E, Kavousi M, Laven JSE, Ikram MA, Roeters van Lennep JE. Aging, Cardiovascular Risk, and SHBG Levels in Men and Women From the General Population. J Clin Endocrinol Metab. 2021;106(10):2890-900.

4. Aribas E, Ahmadizar F, Mutlu U, et al. Sex steroids and markers of micro- and macrovascular damage among women and men from the general population. Eur J Prev Cardiol. 2022;29(9):1322-30.